SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma board will approve financial results

01 Aug 2012 Evaluate
Bal Pharma has informed that a meeting of the board of directors of the company will be held on August 10, 2012, to take record and approve the un-audited financial results of the company for the quarter ended June 30, 2012 and the audited financial results of the company the financial year ended March 31, 2012.

Further, the board will propose issue and allotment of warrants on preferential basis to the promoters and to strategic investors, subject to the member’s approval, to approve the audited accounts of the company for the F.Y. ended March 31, 2012 along with the notice for AGM, directors report and corporate governance report and to decide on the book closure date and AGM date.

The above information is a part of company's filings submitted to BSE.

Bal Pharma Share Price

77.25 0.06 (0.08%)
22-Apr-2026 12:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.50
Dr. Reddys Lab 1220.55
Cipla 1233.50
Zydus Lifesciences 931.50
Lupin 2310.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×